Recombitek Oral (Canada)

Company: Boehringer Ingelheim Animal Health

Bbronc ALC SWD

Dogs

1 mL

Bordetella Bronchiseptica Vaccine, Avirulent Live Culture

Recombitek Oral Indications

For vaccination of healthy dogs and puppies 8 weeks of age or older as an aid in prevention of kennel cough caused by Bordetella bronchiseptica.

Directions and dosage: Aseptically rehydrate the vaccine cake with the sterile diluent supplied. Shake well and draw the required amount back into the syringe. Remove needle from syringe. Use immediately. Place the tip of the syringe (without needle) in the buccal cavity of the dog. Expel one dose (1 mL) of rehydrated vaccine into buccal cavity (see illustration). Historically, annual revaccination with this product has been recommended. The need for annual booster vaccination has not been established for this product. For advice on revaccination frequency, contact your veterinarian or the manufacturer.

Proper Oral Administration

Precautions

This product is designed for oral administration only. Do not vaccinate dogs parenterally. In case of anaphylactoid reaction, administer epinephrine. This product has not been tested in pregnant animals. In case of human exposure, contact a physician. Inactivate unused contents before disposal.

Precautions: For oral use only. Do not vaccinate dogs parenterally. Store out of direct sunlight at 2-8°C. Do not freeze. Do not mix with other products, except as specified on the label.

For use in animals only.

Recombitek^® is a registered trademark in Canada of Boehringer Ingelheim Vetmedica GmbH. Used under license.

Manufactured by:

Boehringer Ingelheim Animal Health USA Inc., Athens, GA 30601 USA

Phone: 1 (888) 637-4251

VLN/PCN 124/1081.05

Distributed in Canada by:

Boehringer Ingelheim Animal Health Canada Inc., Burlington ON L7L 5H4

CPN: 1182171.0